Published in J Gen Intern Med on January 01, 2005
Low rates of African American participation in genetic counseling and testing for BRCA1/2 mutations: racial disparities or just a difference? J Genet Couns (2012) 0.97
Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study. Fam Cancer (2011) 0.93
Personalized medicine and access to health care: potential for inequitable access? Eur J Hum Genet (2012) 0.92
Coherence and completeness of population-based family cancer reports. Cancer Epidemiol Biomarkers Prev (2010) 0.89
Missed opportunities: family history and behavioral risk factors in breast cancer risk assessment among a multiethnic group of women. J Gen Intern Med (2007) 0.89
Social and ethical implications of genomics, race, ethnicity, and health inequities. Semin Oncol Nurs (2008) 0.85
Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer. J Clin Oncol (2016) 0.81
Improving the management of people with a family history of breast cancer in primary care: before and after study of audit-based education. BMC Fam Pract (2013) 0.80
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst (1989) 19.87
Race, gender, and partnership in the patient-physician relationship. JAMA (1999) 13.80
Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med (1999) 7.81
Drug complications in outpatients. J Gen Intern Med (2000) 5.04
Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst (2001) 5.03
Screening for breast cancer: recommendations and rationale. Ann Intern Med (2002) 4.90
Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer (1997) 4.47
American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin (2003) 4.43
Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer (1994) 4.37
Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA (1994) 4.35
BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med (1997) 4.33
Overview of the main outcomes in breast-cancer prevention trials. Lancet (2003) 4.31
Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst (1994) 4.28
Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med (2001) 4.13
Racial and ethnic disparities in the use of health services: bias, preferences, or poor communication? J Gen Intern Med (2003) 4.11
Is the professional satisfaction of general internists associated with patient satisfaction? J Gen Intern Med (2000) 3.83
Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med (1998) 3.06
Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol (2002) 2.80
Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am J Med Genet (1997) 2.79
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA (1997) 2.78
Family history-taking in community family practice: implications for genetic screening. Genet Med (2001) 2.75
The association of race/ethnicity, socioeconomic status, and physician recommendation for mammography: who gets the message about breast cancer screening? Am J Public Health (2001) 2.66
A systematic review of the literature exploring the role of primary care in genetic services. Fam Pract (1999) 2.62
Cancer incidence and mortality, 1973-1995: a report card for the U.S. Cancer (1998) 2.48
Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study. JAMA (1993) 2.45
A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database. JAMA (1993) 2.28
The 'new genetics' and primary care: GPs' views on their role and their educational needs. Fam Pract (1999) 2.28
Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol (2001) 2.25
Cancer statistics by race and ethnicity. CA Cancer J Clin (1998) 2.18
Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol (1997) 2.14
Racial differences in breast carcinoma survival. Cancer (2000) 2.13
Performance of generalized estimating equations in practical situations. Biometrics (1994) 2.12
The duration of ambulatory visits to physicians. J Fam Pract (1999) 2.06
Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst (1999) 2.06
GPs' views on their role in cancer genetics services and current practice. Fam Pract (1999) 1.94
Increasing use of mammography among older, rural African American women: results from a community trial. Am J Public Health (2002) 1.94
Breast cancers among very young premenopausal women (United States). Cancer Causes Control (2003) 1.80
Race-related differences in breast cancer patients. Results of the 1982 national survey of breast cancer by the American College of Surgeons. Cancer (1985) 1.76
Effect of physician and patient gender concordance on patient satisfaction and preventive care practices. J Gen Intern Med (2000) 1.70
Dual effect of parity on breast cancer risk in African-American women. J Natl Cancer Inst (2003) 1.66
Breast cancer genetics in African Americans. Cancer (2003) 1.65
Physicians' knowledge of genetics and genetic tests. Acad Med (1993) 1.62
The excess burden of breast carcinoma in minority and medically underserved communities: application, research, and redressing institutional racism. Cancer (2000) 1.48
Physician knowledge and attitudes towards molecular genetic (DNA) testing of their patients. Clin Genet (1998) 1.47
Ethnicity and variation in breast cancer incidence. Int J Cancer (1997) 1.43
Survival differences in breast cancer among racial/ethnic groups: a population-based study. Cancer Detect Prev (1999) 1.37
Breast cancer risk factors among black women and white women: similarities and differences. Am J Epidemiol (1992) 1.31
The family history in family practice: a questionnaire study. Fam Pract (1997) 1.27
Differences in the quality of care for women with an abnormal mammogram or breast complaint. J Gen Intern Med (2000) 1.25
Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer. Am J Hum Genet (1997) 1.20
Accuracy of family cancer history in breast cancer patients. Eur J Cancer Prev (1994) 1.11
National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel. J Natl Cancer Inst (1997) 1.04
Expanding the role of the family history in primary care. Br J Gen Pract (1999) 1.01
Early use of clinical BRCA1/2 testing: associations with race and breast cancer risk. Am J Med Genet A (2003) 0.99
Differences in the professional satisfaction of general internists in academically affiliated practices in the greater-Boston area. Ambulatory Medicine Quality Improvement Project Investigators. J Gen Intern Med (1998) 0.97
The prevalence of a family history of cancer in general practice. Fam Pract (1995) 0.96
The reliability of recollections of family history: implications for the medical provider. J Cancer Educ (1997) 0.95
Race, ethnicity, and disparities in breast cancer: victories and challenges. Womens Health Issues (2002) 0.93
Population-based estimates of the prevalence of family history of cancer among women. Community Genet (2001) 0.91
Validation of family history of breast cancer and identification of the BRCA1 and other syndromes using a population-based cancer registry. Genet Epidemiol (1996) 0.89
Low incidence of familial breast cancer among Hispanic women. Cancer Causes Control (1992) 0.86
Risk factors for retained instruments and sponges after surgery. N Engl J Med (2003) 8.93
Missed and delayed diagnoses in the ambulatory setting: a study of closed malpractice claims. Ann Intern Med (2006) 7.08
Claims, errors, and compensation payments in medical malpractice litigation. N Engl J Med (2006) 6.70
Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. JAMA (2005) 5.96
Physician-citizens--public roles and professional obligations. JAMA (2004) 4.68
Analysis of errors reported by surgeons at three teaching hospitals. Surgery (2003) 4.66
The reliability of medical record review for estimating adverse event rates. Ann Intern Med (2002) 4.02
Housing instability and food insecurity as barriers to health care among low-income Americans. J Gen Intern Med (2006) 3.90
The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med (2010) 3.78
The rise of litigation in human subjects research. Ann Intern Med (2003) 3.77
Primary care closed claims experience of Massachusetts malpractice insurers. JAMA Intern Med (2013) 3.47
The new medical malpractice crisis. N Engl J Med (2003) 3.41
Medical malpractice. N Engl J Med (2004) 3.38
Obesity--the new frontier of public health law. N Engl J Med (2006) 3.36
The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med (2011) 3.27
Direct-to-consumer marketing of high-technology screening tests. N Engl J Med (2002) 3.17
A middle ground on public accountability. N Engl J Med (2004) 2.72
Missed and delayed diagnoses in the emergency department: a study of closed malpractice claims from 4 liability insurers. Ann Emerg Med (2006) 2.67
Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients. Cancer (2009) 2.63
Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial. Ann Surg (2004) 2.52
Analysis of surgical errors in closed malpractice claims at 4 liability insurers. Surgery (2006) 2.43
Disclosure of medical injury to patients: an improbable risk management strategy. Health Aff (Millwood) (2007) 2.40
Randomized trial of four financial-incentive programs for smoking cessation. N Engl J Med (2015) 2.39
Body mass index, provider advice, and target gestational weight gain. Obstet Gynecol (2005) 2.38
Massachusetts health reform and disparities in coverage, access and health status. J Gen Intern Med (2010) 2.24
Communication factors in the follow-up of abnormal mammograms. J Gen Intern Med (2004) 2.21
Association between language proficiency and the quality of primary care among a national sample of insured Latinos. Med Care (2007) 2.21
Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution. N Engl J Med (2004) 2.18
Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications. Am J Med (2012) 2.13
Trouble getting started: predictors of primary medication nonadherence. Am J Med (2011) 2.09
Shifting terrain in the regulation of off-label promotion of pharmaceuticals. N Engl J Med (2009) 2.04
Secondary use of electronic health record data: spontaneous triggered adverse drug event reporting. Pharmacoepidemiol Drug Saf (2010) 2.03
Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood) (2011) 1.98
Advising patients about patient safety: current initiatives risk shifting responsibility. Jt Comm J Qual Patient Saf (2005) 1.95
Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med (2007) 1.87
Modes of delivery for interventions to improve cardiovascular medication adherence. Am J Manag Care (2010) 1.83
Contribution of cyclooxygenase-2 to elevated biosynthesis of thromboxane A2 and prostacyclin in cigarette smokers. Circulation (2005) 1.82
Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study. Ann Intern Med (2014) 1.78
Predictors and outcomes of frequent emergency department users. Acad Emerg Med (2003) 1.76
The role of medical liability reform in federal health care reform. N Engl J Med (2009) 1.72
Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. J Clin Oncol (2008) 1.70
The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money. Health Aff (Millwood) (2011) 1.64
The pharmaceutical industry versus Medicaid--limits on state initiatives to control prescription-drug costs. N Engl J Med (2004) 1.60
Elucidating the role of place in health care disparities: the example of racial/ethnic residential segregation. Health Serv Res (2012) 1.55
The Leapfrog standards: ready to jump from marketplace to courtroom? Health Aff (Millwood) (2003) 1.52
Liability impact of the hospitalist model of care. J Hosp Med (2014) 1.51
Gender and racial disparities in adherence to statin therapy: a meta-analysis. Am Heart J (2013) 1.46
A comprehensive case management program to improve palliative care. J Palliat Med (2009) 1.44
Conflict in the care of patients with prolonged stay in the ICU: types, sources, and predictors. Intensive Care Med (2003) 1.42
Physician perceptions about generic drugs. Ann Pharmacother (2011) 1.40
Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups. Cancer Epidemiol Biomarkers Prev (2006) 1.39
Prescription drug dispensing limits and patterns. Manag Care Interface (2005) 1.38
Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence. Med Care (2013) 1.38
Are gatekeeper requirements associated with cancer screening utilization? Health Serv Res (2004) 1.35
Integrating multiple social statuses in health disparities research: the case of lung cancer. Health Serv Res (2012) 1.35
Effects of a malpractice crisis on specialist supply and patient access to care. Ann Surg (2005) 1.33
Physicians and drug representatives: exploring the dynamics of the relationship. J Gen Intern Med (2007) 1.32
Healthcare information technology interventions to improve cardiovascular and diabetes medication adherence. Am J Manag Care (2010) 1.32
Rates and predictors of colorectal cancer screening. Prev Chronic Dis (2006) 1.31
Cancer risk assessment: quality and impact of the family history interview. Am J Prev Med (2004) 1.30
The effect of area HMO market share on cancer screening. Health Serv Res (2004) 1.29
Prescription drug insurance coverage and patient health outcomes: a systematic review. Am J Public Health (2015) 1.27
Inconsistent report cards: assessing the comparability of various measures of the quality of ambulatory care. Med Care (2002) 1.26
An electronic health record-based intervention to improve tobacco treatment in primary care: a cluster-randomized controlled trial. Arch Intern Med (2009) 1.26
How the new medicare drug benefit could affect vulnerable populations. Health Aff (Millwood) (2006) 1.21
Due process in investigations of research misconduct. N Engl J Med (2003) 1.20
Defensive medicine and tort reform: a wide view. J Gen Intern Med (2010) 1.17
Ambulatory care adverse events and preventable adverse events leading to a hospital admission. Qual Saf Health Care (2007) 1.16
Changes in health status experienced by women with gestational diabetes and pregnancy-induced hypertensive disorders. J Womens Health (Larchmt) (2005) 1.16
The consequences of requesting "dispense as written". Am J Med (2011) 1.16
Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med (2005) 1.15
Factors affecting breast cancer risk reduction practices among California physicians. Prev Med (2004) 1.14
Caring for patients in a malpractice crisis: physician satisfaction and quality of care. Health Aff (Millwood) (2004) 1.13
Targeting cardiovascular medication adherence interventions. J Am Pharm Assoc (2003) (2012) 1.10
Iatrogenic events resulting in intensive care admission: frequency, cause, and disclosure to patients and institutions. Am J Med (2005) 1.09
Predictors of compliance with the postpartum visit among women living in healthy start project areas. Matern Child Health J (2006) 1.09
Impact of the National Practitioner Data Bank on resolution of malpractice claims. Inquiry (2003) 1.09
Hospital disclosure practices: results of a national survey. Health Aff (Millwood) (2003) 1.07
Correlates of prescription drug use during pregnancy. J Womens Health (Larchmt) (2005) 1.07
Nature of conflict in the care of pediatric intensive care patients with prolonged stay. Pediatrics (2003) 1.07
Comparing electronic health record portals to obtain patient-entered family health history in primary care. J Gen Intern Med (2013) 1.05
Results of a clinical trial on care improvement for the critically ill. Crit Care Med (2003) 1.05
"Health courts" and accountability for patient safety. Milbank Q (2006) 1.04
Moving beyond the typologies of managed care: the example of health plan predictors of screening mammography. Health Serv Res (2004) 1.03
Variation in drug prices at pharmacies: are prices higher in poorer areas? Health Serv Res (2008) 1.00
Cost-effectiveness of oral anticoagulants for treatment of atrial fibrillation. Circ Cardiovasc Qual Outcomes (2013) 0.98
Use of a web-based risk appraisal tool for assessing family history and lifestyle factors in primary care. J Gen Intern Med (2013) 0.98
Accuracy of race, ethnicity, and language preference in an electronic health record. J Gen Intern Med (2014) 0.98